References
- Rubanyi G M. The role of endothelium in cardiovascular homeostasis and disease. J Cardiovasc Pharmacol 1991; 222(Suppl4)S1–14
- Moncada S, Gryglewski R, Bunting S, Vane J R. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 1976; 263: 663–5
- Furchgott R P, Zawadski J V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373–6
- Ignarro L J, Burns P E, Buga G M, Wood K S. Endothelium derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res 1987; 61: 866–79
- Palmer R MJ, Ferrige A G, Moncada S. Nitric oxide release accounts for the biological activity of endothelium derived relaxing factor. Nature 1987; 237: 524–5
- Schulz R, Triggle C R. Role of NO in vascular smooth muscle and cardiac muscle function. Trends Pharmacol Sci 1994; 15: 255–9
- Wennmalm Å. Endothelial nitric oxide and cardiovascular disease. J Intern Med 1994; 235: 317–27
- Moncada S, Palmer B MJ, Higgs E A. Nitric oxide: physiology, pathology and pharmacology. Pharmacol Rev 1991; 43: 109–42
- Lipton S A, Choi Y-R, Pan Z-H. A redox-based mechanism for the protective and neurodestructive effects of nitric oxide and related nitroso-compounds. Lancet 1993; 364: 626–32
- Alanko J, Sievi E, Lähteenmäki T, Mucha I, Riutta A, Vapaatalo H. Effects of NO-donors, SIN-1 and GEA 3175, on prostacyclin and cGMP synthesis in cultured rat endothelial cells. Agents Action 1995; 45: 195–9
- Bauersachs J, Hecker M, Busse R. Display of the characteristics of endothelium-derived hyperpolarizing factor by a cytochrome P450-derived arachidonic acid metabolite in coronary circulation. Br J Pharmacol 1995, (in press)
- Garthwalte J. Nitric oxide signalling in the nervous system. Semin Neurosci 1993; 5: 171–80
- Rand M J. Nitrergic transmission: nitric oxide as a mediator of non-adrenergic, non-cholinergic neuro-effector transmission. Clin Exp Pharmacol Physiol 1992; 19: 147–69
- Änggård E. Nitric oxide: mediator, murderer, and medicine. Lancet 1994; 343: 1199–206
- Vallance P, Collier J. Biology and clinical relevance of nitric oxide. BMJ 1994; 309: 453–7
- Murell W. Nitro-glycerin as a remedy for angina pectoris. Lancet 1879; i: 80–1; 113–5; 151–2; 225–7
- Brunton T L. Lectures on the Actions of Medicine. Macmillan & Co, New York 1897
- Vapaatalo H. NO-donors in cardiology. Pol J Pharmacol 1994; 46: 531–40
- Star R A. Southwestern Internal Medicine Conference: Nitric oxide. Am J Med Sci 1993; 306: 348–58